The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China

To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.ObjectiveTo investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.A total of 169,891 patients in Peking Union Medical College Hospi...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 13; p. 1007257
Main Authors Meng, Jingjing, Yang, Guoxiang, Li, Siting, Luo, Yueming, Bai, Yina, Deng, Chuiwen, Song, Ning, Li, Mengtao, Zeng, Xiaofeng, Hu, Chaojun
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 27.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.ObjectiveTo investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.A total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People's Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively.MethodsA total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People's Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively.The positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody.ResultsThe positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody.The RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification.ConclusionThe RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification.
AbstractList To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.ObjectiveTo investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.A total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People's Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively.MethodsA total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People's Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively.The positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody.ResultsThe positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody.The RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification.ConclusionThe RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification.
ObjectiveTo investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.MethodsA total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People’s Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively.ResultsThe positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody.ConclusionThe RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification.
Author Meng, Jingjing
Deng, Chuiwen
Song, Ning
Luo, Yueming
Yang, Guoxiang
Li, Mengtao
Bai, Yina
Zeng, Xiaofeng
Li, Siting
Hu, Chaojun
AuthorAffiliation 2 Department of Clinical Laboratory, Fifth Affiliated Hospital of Zhengzhou University , Zhengzhou , China
3 Department of Clinical Laboratory, Inner Mongolia People’s Hospital , Hohhot , China
4 Jiangmen Wuyi Hospital of Traditional Chinese Medicine (TCM) (Affiliated Jiangmen TCM Hospital of Ji’nan University) , Jiangmen , China
1 Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education , Beijing , China
AuthorAffiliation_xml – name: 2 Department of Clinical Laboratory, Fifth Affiliated Hospital of Zhengzhou University , Zhengzhou , China
– name: 3 Department of Clinical Laboratory, Inner Mongolia People’s Hospital , Hohhot , China
– name: 1 Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education , Beijing , China
– name: 4 Jiangmen Wuyi Hospital of Traditional Chinese Medicine (TCM) (Affiliated Jiangmen TCM Hospital of Ji’nan University) , Jiangmen , China
Author_xml – sequence: 1
  givenname: Jingjing
  surname: Meng
  fullname: Meng, Jingjing
– sequence: 2
  givenname: Guoxiang
  surname: Yang
  fullname: Yang, Guoxiang
– sequence: 3
  givenname: Siting
  surname: Li
  fullname: Li, Siting
– sequence: 4
  givenname: Yueming
  surname: Luo
  fullname: Luo, Yueming
– sequence: 5
  givenname: Yina
  surname: Bai
  fullname: Bai, Yina
– sequence: 6
  givenname: Chuiwen
  surname: Deng
  fullname: Deng, Chuiwen
– sequence: 7
  givenname: Ning
  surname: Song
  fullname: Song, Ning
– sequence: 8
  givenname: Mengtao
  surname: Li
  fullname: Li, Mengtao
– sequence: 9
  givenname: Xiaofeng
  surname: Zeng
  fullname: Zeng, Xiaofeng
– sequence: 10
  givenname: Chaojun
  surname: Hu
  fullname: Hu, Chaojun
BookMark eNp9kk1vGyEQhldVKjVN8wd64tiL3eVrd-mhUmT1I1KkXtIzYmGwiVhwgXWVH9H_XNa2oqSHcmE0zDwvDO_b5iLEAE3zHrdrSgfx0bppmtekJWSN27YnvH_VXOKuYytKCLt4Fr9prnN-aOtiglLKL5s_9ztA2rvgtPLooPwMKFrkgnEJdEELOkTr55ggawgakI0JZZ0AggtbpEJxqxRNrpFBqabyMTdG4yB_QjcoQUkx7yvNHQDlMpvHRaL8jqgCC6Rc5dBm54J617y2yme4Pu9Xzc-vX-4331d3P77dbm7uVpoxXlbAW8pGQbGxdsTGDIpRYYi2ZugU5ZZixYwmmCvRGz0yjY0WdT4UBOvEyOlVc3vimqge5D65SaVHGZWTx0RMW6lScdqDNMzynoy9Zf3AsLAK92NHBtsTGGlVqKzPJ9Z-Hicwy5OS8i-gL0-C28ltPEjBOSFYVMCHMyDFXzPkIidXR-29ChDnLEn9UTyIoW9rKTmV6jrRnMA-yeBWLl6QRy_IxQvy7IXaNPzTpF1RxcXlOs7_r_UvUITBNg
CitedBy_id crossref_primary_10_3389_fimmu_2024_1359030
Cites_doi 10.1097/BOR.0000000000000834
10.23937/2469-5726/1510073
10.3389/fonc.2021.631038
10.1002/art.34380
10.1111/sji.12803
10.1186/s13317-020-00139-9
10.1111/j.1365-2036.2006.03172.x
10.1186/s13008-018-0038-0
10.1093/labmed/lmy024
10.1136/annrheumdis-2018-214436
10.1038/s41584-021-00573-7
10.1016/j.antiviral.2018.12.017
10.1007/s11882-013-0405-5
10.1007/s12016-018-8718-8
10.1016/j.critrevonc.2018.05.002
10.2174/138955709788452676
10.1111/sji.12848
10.3851/IMP1993
10.1186/1471-230X-13-50
10.1016/j.autrev.2021.102922
10.5114/reum.2018.77976
10.1016/B978-0-12-800097-7.00002-6
10.1034/j.1600-0676.2001.021004272.x
10.1111/pcmr.12854
10.1371/journal.pone.0045392
10.1016/j.cca.2021.07.006
10.15386/cjmed-996
10.1038/s41598-021-87366-w
10.1007/s12026-020-09136-6
10.3748/wjg.v22.i6.1966
10.3109/08916934.2015.1118762
10.1016/j.autrev.2019.102400
10.1111/jvh.12281
10.3389/fimmu.2020.562138
10.1002/cam4.4675
10.3389/fimmu.2015.00041
10.1016/j.jgg.2015.04.002
10.1515/cclm-2017-1152
10.1111/1348-0421.12879
10.1016/j.autrev.2011.06.005
10.1371/journal.pone.0185977
10.1016/j.autrev.2020.102643
10.1016/j.cca.2010.12.019
10.1080/23744235.2019.1690676
10.1007/s10875-012-9827-4
10.1016/j.transproceed.2004.09.070
10.1016/j.clim.2016.10.004
10.1089/vim.2019.0012
10.1369/0022155414543853
10.1007/s12026-014-8515-2
10.1016/j.yexcr.2017.10.030
10.1016/j.cca.2019.06.027
ContentType Journal Article
Copyright Copyright © 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu.
Copyright © 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu
Copyright_xml – notice: Copyright © 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu.
– notice: Copyright © 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fimmu.2022.1007257
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_d4f572b7f478419fa17b628f72eb315a
PMC9552219
10_3389_fimmu_2022_1007257
GrantInformation_xml – fundername: ;
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
7X8
5PM
ID FETCH-LOGICAL-c445t-e5034b931dffb1dd8a439d2cfd86a35f31a4dc215a97dcb4c1dc92023e9469b53
IEDL.DBID M48
ISSN 1664-3224
IngestDate Wed Aug 27 01:30:01 EDT 2025
Thu Aug 21 18:39:14 EDT 2025
Fri Jul 11 12:07:47 EDT 2025
Thu Apr 24 23:04:47 EDT 2025
Tue Jul 01 02:11:28 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c445t-e5034b931dffb1dd8a439d2cfd86a35f31a4dc215a97dcb4c1dc92023e9469b53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Markus Wilhelmi, Bürgerhospital Frankfurt, Germany; Mirjana Sefik Bukilica, Belgrade University, Serbia
This article was submitted to Autoimmune and Autoinflammatory Disorders: Autoimmune Disorders, a section of the journal Frontiers in Immunology
Edited by: Alessandro Granito, University of Bologna, Italy
These authors have contributed equally to this work and share first authorship
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2022.1007257
PQID 2725189870
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_d4f572b7f478419fa17b628f72eb315a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9552219
proquest_miscellaneous_2725189870
crossref_primary_10_3389_fimmu_2022_1007257
crossref_citationtrail_10_3389_fimmu_2022_1007257
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-09-27
PublicationDateYYYYMMDD 2022-09-27
PublicationDate_xml – month: 09
  year: 2022
  text: 2022-09-27
  day: 27
PublicationDecade 2020
PublicationTitle Frontiers in immunology
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Im (B9) 2020; 52
Juda (B16) 2014; 62
Damoiseaux (B12) 2019; 78
Zhang (B38) 2019; 91
Zheng (B39) 2020; 11
Ma (B1) 2019; 496
Carcamo (B15) 2014; 308
Granito (B48) 2021; 17
Wang (B27) 2019; 90
Keppeke (B24) 2012; 7
Assandri (B45) 2019; 12
Calise (B13) 2015; 6
Dinse (B40) 2017; 12
da Silva Sacerdote (B31) 2020; 68
Carcamo (B20) 2013; 33
Keppeke (B22) 2016; 173
Katayama (B51) 2022; 21
Bogdanos (B44) 2021; 521
Barth (B6) 2022; 11
Calise (B25) 2018; 56
Novembrino (B35) 2014; 21
Keppeke (B54) 2020; 33
Chang (B53) 2017; 361
Vlagea (B4) 2018; 127
Feldrihan (B34) 2019; 92
Dhaouadi (B36) 2019; 32
Keppeke (B32) 2016; 22
Wang (B5) 2021; 11
Alsaed (B41) 2021; 11
Stochmal (B3) 2020; 58
Tiniakou (B2) 2021; 33
Sur (B8) 2018; 49
Op De Beeck (B11) 2011; 10
Peker (B33) 2021; 65
Van Hoovels (B29) 2020; 11
Assandri (B19) 2021; 14
Keppeke (B21) 2014; 60
Pisetsky (B28) 2019; 18
Grygiel-Gorniak (B10) 2018; 56
Keppeke (B52) 2018; 13
Keppeke (B50) 2019; 162
Granito (B46) 2006; 24
Stinton (B18) 2013; 13
Covini (B14) 2012; 17
Keppeke (B17) 2015; 42
Granito (B49) 2009; 9
Vannozzi (B43) 2004; 36
Satoh (B26) 2012; 64
Bhagat (B7) 2014; 14
Bogdanos (B47) 2011; 412
Magerl (B37) 2019; 5
Fox (B42) 2001; 21
Calise (B30) 2020; 19
Climent (B23) 2016; 49
References_xml – volume: 33
  year: 2021
  ident: B2
  article-title: Insights into origins and specificities of autoantibodies in systemic sclerosis
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0000000000000834
– volume: 5
  year: 2019
  ident: B37
  article-title: ANA-Hep2 positive with anti-rods and rings pattern in a child without hepatitis c under treatment: Case report
  publication-title: J Rheumatic Dis Treat
  doi: 10.23937/2469-5726/1510073
– volume: 11
  year: 2021
  ident: B5
  article-title: Antinuclear antibodies with a nucleolar pattern are associated with a significant reduction in the overall survival of patients with leukemia: A retrospective cohort study
  publication-title: Front Oncol
  doi: 10.3389/fonc.2021.631038
– volume: 64
  year: 2012
  ident: B26
  article-title: Prevalence and sociodemographic correlates of antinuclear antibodies in the united states
  publication-title: Arthritis Rheum
  doi: 10.1002/art.34380
– volume: 90
  start-page: e12803
  year: 2019
  ident: B27
  article-title: Anti-centrosome antibodies: Prevalence and disease association in Chinese population
  publication-title: Scand J Immunol
  doi: 10.1111/sji.12803
– volume: 11
  start-page: 17
  year: 2020
  ident: B29
  article-title: Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns: results of an international survey
  publication-title: Auto Immun Highlights
  doi: 10.1186/s13317-020-00139-9
– volume: 24
  year: 2006
  ident: B46
  article-title: Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim-like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2006.03172.x
– volume: 13
  start-page: 5
  year: 2018
  ident: B52
  article-title: IMP/GTP balance modulates cytoophidium assembly and IMPDH activity
  publication-title: Cell Div
  doi: 10.1186/s13008-018-0038-0
– volume: 49
  year: 2018
  ident: B8
  article-title: Antinuclear antibodies: Marker of diagnosis and evolution in autoimmune diseases
  publication-title: Lab Med
  doi: 10.1093/labmed/lmy024
– volume: 78
  year: 2019
  ident: B12
  article-title: Clinical relevance of HEp-2 indirect immunofluorescent patterns: the international consensus on ANA patterns (ICAP) perspective
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2018-214436
– volume: 17
  start-page: 244
  year: 2021
  ident: B48
  article-title: Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/s41584-021-00573-7
– volume: 162
  year: 2019
  ident: B50
  article-title: Ribavirin induces widespread accumulation of IMP dehydrogenase into rods/rings structures in multiple major mouse organs
  publication-title: Antiviral Res
  doi: 10.1016/j.antiviral.2018.12.017
– volume: 14
  start-page: 405
  year: 2014
  ident: B7
  article-title: Utility of immunologic testing in suspected rheumatologic disease
  publication-title: Curr Allergy Asthma Rep
  doi: 10.1007/s11882-013-0405-5
– volume: 58
  start-page: 40
  year: 2020
  ident: B3
  article-title: Antinuclear antibodies in systemic sclerosis: an update
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-018-8718-8
– volume: 127
  year: 2018
  ident: B4
  article-title: Antinuclear antibodies and cancer: A literature review
  publication-title: Crit Rev Oncol Hematol
  doi: 10.1016/j.critrevonc.2018.05.002
– volume: 9
  year: 2009
  ident: B49
  article-title: Diagnosis and therapy of autoimmune hepatitis
  publication-title: Mini Rev Med Chem
  doi: 10.2174/138955709788452676
– volume: 91
  year: 2019
  ident: B38
  article-title: The value of anti-rods and rings antibodies in Western China population: A retrospective study
  publication-title: Scandinavian J Immunol
  doi: 10.1111/sji.12848
– volume: 17
  year: 2012
  ident: B14
  article-title: Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis c
  publication-title: Antivir Ther
  doi: 10.3851/IMP1993
– volume: 13
  start-page: 50
  year: 2013
  ident: B18
  article-title: Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis c infection
  publication-title: BMC Gastroenterol
  doi: 10.1186/1471-230X-13-50
– volume: 21
  start-page: 102922
  year: 2022
  ident: B51
  article-title: Anti-rods/rings autoantibodies in a patient with pancreatic injury
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2021.102922
– volume: 56
  year: 2018
  ident: B10
  article-title: Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications
  publication-title: Reumatologia
  doi: 10.5114/reum.2018.77976
– volume: 14
  start-page: 89
  year: 2021
  ident: B19
  article-title: Acute severe autoimmune hepatitis with anti-rods and rings autoantibodies; literature first evidence
  publication-title: Gastroenterol Hepatol Bed Bench
– volume: 12
  start-page: 76
  year: 2019
  ident: B45
  article-title: Primary biliary cholangitis with contemporary presence of anti-mithocondrial and anti-rods and rings autoantibodies: literature first case
  publication-title: Gastroenterol Hepatol Bed Bench
– volume: 308
  start-page: 35
  year: 2014
  ident: B15
  article-title: Molecular cell biology and immunobiology of mammalian rod/ring structures
  publication-title: Int Rev Cell Mol Biol
  doi: 10.1016/B978-0-12-800097-7.00002-6
– volume: 21
  year: 2001
  ident: B42
  article-title: Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis
  publication-title: Liver
  doi: 10.1034/j.1600-0676.2001.021004272.x
– volume: 33
  year: 2020
  ident: B54
  article-title: IMP dehydrogenase rod/ring structures in acral melanomas
  publication-title: Pigment Cell Melanoma Res
  doi: 10.1111/pcmr.12854
– volume: 7
  start-page: e45392
  year: 2012
  ident: B24
  article-title: Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-alpha
  publication-title: PloS One
  doi: 10.1371/journal.pone.0045392
– volume: 521
  start-page: 199
  year: 2021
  ident: B44
  article-title: Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2021.07.006
– volume: 92
  start-page: 87
  year: 2019
  ident: B34
  article-title: Long-term antiviral hepatitis c treatment associated with rods and ring cytoplasmic antibodies
  publication-title: Med Pharm Rep
  doi: 10.15386/cjmed-996
– volume: 11
  start-page: 8229
  year: 2021
  ident: B41
  article-title: Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases
  publication-title: Sci Rep
  doi: 10.1038/s41598-021-87366-w
– volume: 68
  year: 2020
  ident: B31
  article-title: Anti-rod and ring antibodies in patients with chronic hepatitis c using direct-acting antivirals
  publication-title: Immunologic Res
  doi: 10.1007/s12026-020-09136-6
– volume: 22
  year: 2016
  ident: B32
  article-title: Anti-rods/rings autoantibody generation in hepatitis c patients during interferon-alpha/ribavirin therapy
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v22.i6.1966
– volume: 49
  year: 2016
  ident: B23
  article-title: Clinical correlates of the “rods and rings” antinuclear antibody pattern
  publication-title: Autoimmunity
  doi: 10.3109/08916934.2015.1118762
– volume: 18
  start-page: 102400
  year: 2019
  ident: B28
  article-title: ANA as an entry criterion for the classification of SLE
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2019.102400
– volume: 21
  year: 2014
  ident: B35
  article-title: Interferon-ribavirin therapy induces serum antibodies determining ‘rods and rings’ pattern in hepatitis c patients
  publication-title: J Viral Hepat
  doi: 10.1111/jvh.12281
– volume: 11
  year: 2020
  ident: B39
  article-title: Anti-DFS70 antibodies among patient and healthy population cohorts in China: Results from a multicenter training program showing spontaneous abortion and pediatric systemic autoimmune rheumatic diseases are common in anti-DFS70 positive patients
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.562138
– volume: 11
  year: 2022
  ident: B6
  article-title: Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study
  publication-title: Cancer Med
  doi: 10.1002/cam4.4675
– volume: 6
  year: 2015
  ident: B13
  article-title: Anti-Rods/Rings: A human model of drug-induced autoantibody generation
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2015.00041
– volume: 42
  year: 2015
  ident: B17
  article-title: Assembly of IMPDH2-based, CTPS-based, and mixed rod/ring structures is dependent on cell type and conditions of induction
  publication-title: J Genet Genomics
  doi: 10.1016/j.jgg.2015.04.002
– volume: 56
  year: 2018
  ident: B25
  article-title: Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2017-1152
– volume: 65
  year: 2021
  ident: B33
  article-title: The relevance between anti-rods/rings antibody and different treatment regimens in chronic hepatitis c virus infection
  publication-title: Microbiol Immunol
  doi: 10.1111/1348-0421.12879
– volume: 10
  year: 2011
  ident: B11
  article-title: Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2011.06.005
– volume: 12
  start-page: e0185977
  year: 2017
  ident: B40
  article-title: Antinuclear antibodies and mortality in the national health and nutrition examination survey (1999-2004)
  publication-title: PloS One
  doi: 10.1371/journal.pone.0185977
– volume: 19
  start-page: 102643
  year: 2020
  ident: B30
  article-title: Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2020.102643
– volume: 412
  year: 2011
  ident: B47
  article-title: Disease-specific autoantibodies in primary biliary cirrhosis
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2010.12.019
– volume: 52
  year: 2020
  ident: B9
  article-title: Antinuclear antibodies in infectious diseases
  publication-title: Infect Dis (Lond)
  doi: 10.1080/23744235.2019.1690676
– volume: 33
  year: 2013
  ident: B20
  article-title: Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-012-9827-4
– volume: 36
  year: 2004
  ident: B43
  article-title: An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipients
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2004.09.070
– volume: 173
  year: 2016
  ident: B22
  article-title: Differential capacity of therapeutic drugs to induce Rods/Rings structures in vitro and in vivo and generation of anti-Rods/Rings autoantibodies
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2016.10.004
– volume: 32
  year: 2019
  ident: B36
  article-title: Association of autoantibody to rods and rings with hepatitis c outcome and viral load
  publication-title: Viral Immunol
  doi: 10.1089/vim.2019.0012
– volume: 62
  year: 2014
  ident: B16
  article-title: Ultrastructure of cytoplasmic and nuclear inosine-5’-monophosphate dehydrogenase 2 “rods and rings” inclusions
  publication-title: J Histochem Cytochem
  doi: 10.1369/0022155414543853
– volume: 60
  start-page: 38
  year: 2014
  ident: B21
  article-title: Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-alpha
  publication-title: Immunol Res
  doi: 10.1007/s12026-014-8515-2
– volume: 361
  year: 2017
  ident: B53
  article-title: CTP synthase forms the cytoophidium in human hepatocellular carcinoma
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2017.10.030
– volume: 496
  year: 2019
  ident: B1
  article-title: Anti-golgi antibodies: Prevalence and disease association in Chinese population
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2019.06.027
SSID ssj0000493335
Score 2.322535
Snippet To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.ObjectiveTo investigate the distribution and...
ObjectiveTo investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.MethodsA total of 169,891 patients in...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 1007257
SubjectTerms anti-nuclear antibody (ANA)
anti‐rods/rings(anti-RR)
autoimmune diseases (AIDs)
hepatitis C
Immunology
prevalence
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlEOiltElLt0mDArkFk-i1snrbhoQlkJwSyE1IlkS37Npl10vIj8h_zozsDetLc8nN2DJ6zHjmG2v0DSEnBgyvT4oXLJSikEm5wkNkUYBv9wkQuRMKTyPf3I6n9_L6QT1slfrCnLCOHrhbuLMA72vudZK4Q2aSY9qPeZk0hzCQqQyNwOdtBVN_O9wrhFDdKRmIwsxZmi0Wa4gHOc-JARz90ZYnyoT9A5Q5zJHccjpXn8mnHi3SSTfKL-RDrPfIblc_8mmfPIOQ6eZsI0Xe7kibRHEbGg0ZxcHUTZqvm2VmbaoiBYxKwVJA9Ao-i8KyzgowoSu4ChR_8a3yPd9gcuEvOqHL2C6bzXFMmslosYv2saE4ZgCP0B3NVbi_kvury7uLadHXVygqKVVbRHUupDeChZQ8C6F0gE4Cr1IoxyCjJJiToQJM4IwOlZcVC5XBcuvRQFDtlfhGduqmjt8JBUkjVTzIBCGKD-48lU5rgEuByyDNiLDNWtuqJx_HGhhzC0EIysdm-ViUj-3lMyKnr-_866g3_tv6N4rwtSXSZucboEy2Vyb7ljKNyPFGASx8Zrh34urYrFcW5qZYacC6jYgeaMagx-GTevYnE3YbBSiXmR_vMcQD8hGnjSkrXB-SnXa5jj8BF7X-KH8CLx_nD3k
  priority: 102
  providerName: Directory of Open Access Journals
Title The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China
URI https://www.proquest.com/docview/2725189870
https://pubmed.ncbi.nlm.nih.gov/PMC9552219
https://doaj.org/article/d4f572b7f478419fa17b628f72eb315a
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9QwFA7riuCLeMXxskTwTaKbW9MIIqu4LsL65MC8laZJdJbZRjsddH-E_9lz0naxoIIvw0zaaS7n5JzvNMl3CHlqwfC6qAXjvpRMRV0zB5EFA9_uIiDyWmo8jXz6sThZqg8rvdojU7qjcQC3fwztMJ_Usts8__Ht4jVM-FcYcYK_fRHX5-c7CPWEyGv-oIRXyFXwTAYzGpyOcP9sQMNS5pybvCgUA11Wwzmavzxm5qsypf8Mh853Uf7mlo5vkhsjnqRHgwLcInuhvU2uDRkmL-6Qn6AGdDr9SJHZO9AUKS5Uo6mj2Jg2xc0udZnXqQkUUCwFWwLxLXg1CgO_ZmBkt_DNU3wJuM1lLuH2w5f0iHah79J0YJNmulqsov-eKLYZ4CVUR3Oe7rtkefzu09sTNmZgYI1SumdBH0rlrOQ-Rse9L2vAL1400ZcFSDFKXivfAGqorfGNUw33jcWE7MFC2O20vEf229SG-4SCLiCZvAgOQYzz9WEsa2MAUHmhvLILwqexrpqRnhyzZGwqCFNQPlWWT4XyqUb5LMizy_98Hcg5_nn3GxTh5Z1IrJ0LUve5Gudp5UFdjXAmKlyQtbHmxhWijNhwCf1ckCeTAlQwEXF1pW5D2m0r6JvmpQX7tyBmphmzGudX2vWXTOltNeBgbh_8V4cekuv4E3evCPOI7PfdLjwGiNS7g_xqAT7fr_hBngO_AEaME3c
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+clinical+value+of+indirect+immunofluorescence+for+screening+anti-rods+and+rings+antibodies%3A+A+retrospective+study+of+two+centers+in+China&rft.jtitle=Frontiers+in+immunology&rft.au=Meng%2C+Jingjing&rft.au=Yang%2C+Guoxiang&rft.au=Li%2C+Siting&rft.au=Luo%2C+Yueming&rft.date=2022-09-27&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=13&rft_id=info:doi/10.3389%2Ffimmu.2022.1007257&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fimmu_2022_1007257
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon